down arrow

ERIS Lifescience

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,361.10
21.1 (1.57%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.29 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
727.45
741.17
719.72
550.93
486.30
505.30
466.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
727.45
741.17
719.72
550.93
486.30
505.30
466.62
Raw Material Cost
69.43
72.16
66.47
51.17
38.91
48.17
39.56
Purchase of Finished goods
133.22
118.35
125.57
58.51
50.03
53.77
39.20
(Increase) / Decrease In Stocks
-25.77
-4.24
-11.45
8.50
-0.07
-7.34
-0.37
Employee Cost
125.39
125.63
132.62
102.48
98.68
98.53
104.13
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
174.87
164.76
156.52
181.84
123.24
131.03
114.35
Total Expenditure (Excl Depreciation)
477.14
476.66
469.73
402.50
310.79
324.16
296.87
Operating Profit (PBDIT) excl Other Income
250.31
264.51
249.99
148.43
175.51
181.14
169.75
Other Income
4.22
4.55
1.64
15.15
4.20
3.48
0.99
Operating Profit (PBDIT)
254.53
269.06
251.63
163.58
179.71
184.62
170.74
Interest
57.17
59.47
60.37
33.03
18.12
16.30
17.36
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
197.36
209.59
191.26
130.55
161.59
168.32
153.38
Depreciation
81.20
80.48
75.94
53.90
45.72
42.09
40.89
Profit Before Tax
116.16
129.11
115.32
76.65
115.87
126.24
112.49
Tax
29.23
32.76
25.90
-2.98
14.41
3.92
18.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
86.93
96.35
89.42
79.63
101.46
122.31
93.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
86.93
96.35
89.42
79.63
101.46
122.31
93.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.30
4.76
6.24
8.67
-1.28
-1.12
-1.21
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
83.63
91.59
83.18
70.96
102.74
123.43
94.86
Equity Capital
13.61
13.61
13.61
13.60
13.60
13.60
13.60
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.14
6.73
6.11
5.22
7.55
9.08
6.97
Diluted Earnings per share
6.14
6.72
6.1
5.21
7.54
9.06
6.97
Operating Profit Margin (Excl OI)
34.66%
35.8%
34.93%
27.12%
36.3%
36.19%
36.9%
Gross Profit Margin
27.33%
28.36%
26.73%
23.85%
33.42%
33.63%
33.34%
PAT Margin
12.04%
13.04%
12.5%
14.55%
20.99%
24.44%
20.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2024 is 49.59% vs 14.89% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2024 is -18.60% vs 0.86% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is 42.62% vs 27.91% in Dec 2023

stock-summary

Interest

YoY Growth in quarter ended Dec 2024 is 215.51% vs 504.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023

Compare Quarterly Results Of ERIS Lifescience With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
727.45
3,230.00
-2,502.55
-77.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
727.45
3,230.00
-2,502.55
-77.48%
Raw Material Cost
69.43
536.11
-466.68
-87.05%
Purchase of Finished goods
133.22
387.30
-254.08
-65.60%
(Increase) / Decrease In Stocks
-25.77
11.81
-37.58
-318.20%
Employee Cost
125.39
709.71
-584.32
-82.33%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
174.87
755.27
-580.40
-76.85%
Total Expenditure (Excl Depreciation)
477.14
2,400.20
-1,923.06
-80.12%
Operating Profit (PBDIT) excl Other Income
250.31
829.80
-579.49
-69.83%
Other Income
4.22
77.32
-73.10
-94.54%
Operating Profit (PBDIT)
254.53
907.12
-652.59
-71.94%
Interest
57.17
220.93
-163.76
-74.12%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
197.36
686.19
-488.83
-71.24%
Depreciation
81.20
192.30
-111.10
-57.77%
Profit Before Tax
116.16
497.33
-381.17
-76.64%
Tax
29.23
112.81
-83.58
-74.09%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
86.93
381.08
-294.15
-77.19%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
86.93
381.08
-294.15
-77.19%
Share in Profit of Associates
0.00
3.44
-3.44
-100.00%
Minority Interest
3.30
4.29
-0.99
-23.08%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
83.63
380.23
-296.60
-78.01%
Equity Capital
13.61
40.06
-26.45
-66.03%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.14
9.49
-3.35
-35.30%
Diluted Earnings per share
6.14
9.44
-3.30
-34.96%
Operating Profit Margin (Excl OI)
34.66%
25.69%
0.00
8.97%
Gross Profit Margin
27.33%
21.24%
0.00
6.09%
PAT Margin
12.04%
11.90%
0.00
0.14%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 727.45 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -1.85% vs 2.98% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 49.59% vs 14.89% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 83.63 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -8.69% vs 10.11% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -18.60% vs 0.86% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 250.31 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -5.37% vs 5.81% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 42.62% vs 27.91% in Dec 2023

Quarterly - Interest
Interest 57.17 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -3.87% vs -1.49% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 215.51% vs 504.00% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.66%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023